Red Light Holland

Taking Psilocybin From Underground to Mainstream

This Red Light Holland profile is part of a paid investor education campaign.*

Overview

Red Light Holland (CSE:TRIP) is a psychedelics company focused on the production and sale of a premium brand of “magic” truffles in the Netherlands. The company intends to target the Netherlands’ recreational psychedelics market, where the company is focused on its plan to create a European Union GMP-certified production facility capable of producing and supplying medical-grade magic truffles. In order to guide the company’s future operations and establish a global reach in the psychedelics market, former Canopy Growth CEO Bruce Linton has joined the Red Light Holland team as chair of its advisory board.

Psychedelic products such as truffles that contain psilocybin or psilocin are commonly referred to as “magic”. These compounds have psychoactive properties that can induce strong psychological responses in human beings, altering the consciousness of those that consume them. In the Netherlands, wet “magic” truffles are widely available in smart shops across the country. There are believed to be nearly 100 smart shops located across Holland, with an annual market value of approximately 100 million euros according to a press release from Pharmadrug Inc.

Red-Light-Holland-Mushrooms

Truffles and mushrooms are part of the same fungus but grow in slightly different environments producing different effects. Truffles are found underground as a vegetative colony known as mycelium, while mushrooms are similar to the “fruit” of the colony that is produced when growing conditions are optimal. Truffles are generally smaller, wet, and similar in size. Mushrooms on the other hand can grow to different sizes and shapes, and often contain varying amounts of psilocybin or psilocin.

Red Light Holland is currently developing a microdosing kit that includes the optimal amount of psychoactive ingredients in each truffle to promote responsible recreational use. In June 2020 Red Light Holland unveiled its Microdosing Packs which it intends to introduce to the market in collaboration with McSmart, one of the Netherland’s prominent truffle growers, distributors and smart shop owners. Together the two companies have initiated the development of psychedelic truffle microdosing packs that are to be supplied, produced, and packaged by McSmart under the Red Light Holland brand.

Under the terms of the agreement, McSmart has also agreed to market and sell Red Light Holland’s microdosing products within the Netherlands, beginning with three of its smart shops. Together Red Light Holland and McSmart intend to capitalize on market interest and launch the Microdosing Packs as soon as possible.

In 2018, the United States FDA provided its Breakthrough Therapy designation for a psilocybin-based therapy for treatment-resistant depression. The FDA’s Breakthrough Therapy designation is intended for drugs that have the potential to treat a serious or life-threatening disease or condition that has previously demonstrated the ability to substantially improve existing therapies or treatments.

Red Light Holland is working to normalize the use of compounds such as psilocybin, which has shown potential for remedial uses. “Red Light Holland’s goal is to, over time, help make the relatively unknown ‘magic truffle’ a familiar name across the world. We are currently setting up to grow, distribute and market a premium brand of magic truffles to the legal, recreational market within the Netherlands, and we can’t wait to shift the existing paradigm to direct further attention to the legal and responsible use of magic truffles,” said Red Light Holland CEO Todd Shapiro. In order to inform the company’s development goals, Red Light Holland has engaged former Canadian Health Minister Tony P. Clement to join the team’s advisory board. As Senior Advisor, Clement is expected to work with Linton and Red Light Holland’s advisory team to provide strategic advice and guide future business development.

Moving forward, Red Light Holland intends to develop two divisions for its psilocybin business. Red Light Holland’s recreational products will be the focus of one division and its counterpart, Scarlette Lillie Science and Innovation, will be the home of the company’s medical research efforts. The company intends to use Scarlette Lillie Science and Innovation to work with researchers and medical institutions to improve the global understanding of psychedelics and their effects. Red Light Holland is also pursuing online retail opportunities to offer both its branded microdosing products and company merchandise.

Red Light Holland’s Company Highlights

  • Currently focused on the Netherlands, where magic truffles are commonly sold in smart shops across the country
  • Working towards establishing an EU GMP certified production and distribution facility of magic truffles based in the Netherlands
  • Partnered with McSmart to supply, package and produce Red Light Holland’s microdosing packs under the Red Light Holland brand in the Netherlands, including three of McSmart’s smart shop locations
  • Working with cannabis industry pioneer Bruce Linton in order to help guide the company through an emerging industry that is analogous to the early stage cannabis industry
  • Signed former Canadian Health Minister Tony P. Clement as Senior Advisor in order to aid in the company’s goal of establishing a global reach in the psychedelic space
  • Signed comedian Russel Peters as Chief Creative Officer to help craft the company’s brand and vision moving forward
  • Established the Scarlette Lillie Science and Innovation division to explore the potential medical and health benefits of psilocybin and whole fungi-medicine

Red Light Holland’s Magic Truffles

Red Light Holland’s flagship product is expected to be a premium microdosing kit that includes a number of optimally dosed magic truffles in order to promote responsible recreational consumption. Microdosing is the act of consuming a relatively small amount of a powerful compound, often a psychedelic substance such as psilocybin, in order to benefit from some of the less intoxicating effects of the substance. By offering a safe and effective microdose, Red Light Holland hopes to encourage consumers to enjoy its non-synthetic magic truffle in moderation.

Within the Netherlands, Red Light Holland intends to work with McSmart to market and sell the company’s microdosing packs. Together the two companies have initiated the development of psychedelic truffle microdosing packs that are to be supplied, produced, and packaged by McSmart under the Red Light Holland brand. Under the terms of the agreement, McSmart has also agreed to market and sell Red Light Holland’s microdosing products within the Netherlands including three of its smart shops. Together Red Light Holland and McSmart intend to capitalize on market interest and launch the Microdosing Packs as soon as possible.

In the Netherlands, wet “magic” truffles are commonly found in smart shops across the country. According to a May 2020 press release, there are approximately 100 smart shops located across Holland that together generate annual revenue of 100 million euros.

Truffles are found underground as a vegetative colony known as mycelium, while mushrooms are similar to the “fruit” of the vegetative colony that is produced when conditions are optimal. Truffles are generally smaller, wet, and similar in size. Mushrooms on the other hand can grow to different sizes and shapes, and often contain varying amounts of psilocybin or psilocin. The even psychoactive makeup of truffles has the potential to enable more consistent user products, particularly those consumed in microdoses.

Moving forward, Red Light Holland also intends to offer a top-tier line of merchandise expected to be made available through the company’s website.

Red Light Holland’s Management Team

Todd Shapiro – Co-Founder, CEO & Director

After being a top-rated Radio Show host & a brilliant Marketing Entrepreneur with over 20 years of experience, Todd Shapiro has recently moved on from mainstream media to concentrate his efforts on being the CEO of Red Light Holland. Shapiro also has an incredible history as one of North America’s most professional & effective Brand Ambassadors and Influencers having worked with Canopy Growth, Samsung, Canada Goose, Canadian Tire & Boveda Inc.

Bruce Linton – Chair of Advisory Board

Founder & former Chairman, CEO and Co-CEO of Canopy Growth Corporation (CGC) formerly Tweed Marijuana Incorporated, a cannabis company based in Smiths Falls, Ontario, Canada. Bruce founded Tweed in 2013 and renamed it Canopy Growth Corporation in 2015. Canopy Growth Corporation was the first cannabis company in North America to be listed on a major stock exchange (TSX-V in April 2014 and TSX in July 2016) and to be included on a major stock index (S&P/TSX Composite Index in March 2017). Bruce led CGC from a TSX-V listed start-up company with an $80 million market cap to an NYSE/TSX listed company (S&P/TSX60) including more than 30 M&A activities. Ranking number one on the TSX30 with a market cap of over $20 billion by the summer of 2019.

Tony P. Clement – Senior Advisor to Advisory Board

Mr. Clement served in senior roles in Prime Minister Stephen Harper’s Cabinet (2006-2015), as Health Minister, Industry Minister and President of the Treasury Board. As a business entrepreneur, he has also led information technology companies, and served on the board of directors on information technology and health care companies, having provided strategic advice both nationally and internationally. Having both national and international business experience, Mr. Clement’s engagement magnifies the Company’s commitment to assembling the group of skilled leaders necessary to build its business in the early stage of this emerging industry.

Hans Derix – President

Hans is a certified Substance Abuse Therapist (APCB) and member of the Association of Addiction Professionals (NAADAC) with over a decade of experience in the field of addiction treatment. He is the founder and managing director of Sensum, Asia’s first and only addiction treatment provider specialized in round-the-clock, one-on-one, in-home rehab services.

Kyle Appleby – CFO

Kyle spent the first 10 years of his career working in public accounting where he worked in both audit and advisory practices working with private companies and investment funds. In 2007 Kyle left the world of public accounting to focus on providing management and accounting services to public companies across a variety of industries including cannabis, agriculture, technology, mining, crypto-currency and others.

Brad J. Lamb, Chairman Of The Board of Directors

Long considered Toronto’s top condominium broker, Brad J. Lamb is also one of the cities most prominent developers. He is a driving force behind Canada’s burgeoning real estate market. As CEO of Brad J. Lamb Realty Inc. and Lamb Development Corp Brad has 30 years of widespread industry experience. He is responsible for the marketing and sales campaigns of over 130 condominium projects across six major Canadian cities.

Ann Barnes, Director

Ann has acted as corporate counsel and General Counsel for a number of private and publicly held companies, including Manulife Financial, TSN, Cott Corporation, and Insight Sports. She left her legal career to focus on her entrepreneurial passions for healthy food and plant-based wellness. She founded and operated a chia and hemp-based food company, published two health food cookbooks, and developed a social media following of over 31,000 people. She is a well-respected public speaker with a popular TEDx talk and an active advocate for plant-based wellness.

 

Forward-Looking Statements and Third Party Data

Certain information in this profile constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this profile that are not statements of historical fact may be deemed to be forward-looking statements. Forward looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements necessarily involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Readers are further cautioned that the assumptions used in the preparation of such forward-looking statements (including, but not limited to, the assumption that (i) Red Light Holland Corp. (the “Company”) will be able to execute on its business plan and/or enter into the medical psychedelics market as proposed, (ii) the Company will receive one or multiple licenses, permits, and authorizations from time to time necessary to execute on its business plan and/or enter into the medical psychedelics market, (iii) the Company’s financial condition and development plans do not change as a result of unforeseen events, (iv) there will continue to be a demand, and market opportunity, for the Company’s product offerings, (v) the Company will be able to establish, preserve and develop its brand, and (iv) the Company will be successful in attracting and retaining required personnel), although considered reasonable by management of the Company at the time of preparation, may prove to be imprecise and result in actual results differing materially from those anticipated, and as such, undue reliance should not be placed on forward-looking statements. The forward-looking statements included in this profile are made as of the date of this profile and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws. Forward-looking statements, forward-looking financial information and other metrics presented herein are not intended as guidance or projections for the periods referenced herein or any future periods, and in particular, past performance is not an indicator of future results and the results of the Company in this press release may not be indicative of, and are not an estimate, forecast or projection of the Company’s future results. Forward-looking statements contained in this profile are expressly qualified by this cautionary statement.

This profile includes market, industry data, and statistical information that has been obtained from third party sources, including industry publications. Although the Company believes that the industry data is accurate and that its estimates and assumptions are reasonable, there is no assurance as to the accuracy or completeness of such data. Third party sources generally state that the information contained therein has been obtained from sources believed to be reliable, but there is no assurance as to the accuracy or completeness of included information. Although the data is believed to be reliable, the Company has not independently verified any of the data from third-party sources referred to in this profile or ascertained the underlying economic assumptions relied upon by such sources.

 


 

*Disclaimer: This profile is sponsored by Red Light Holland (CSE:TRIP). This profile provides information which was sourced by the Investing News Network (INN) and approved by Red Light Holland, in order to help investors learn more about the company. Red Light Holland is a client of INN. The company’s campaign fees pay for INN to create and update this profile.

INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.

The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with Red Light Holland and seek advice from a qualified investment advisor.